Absorption Rate Constant (ka) Calculator
Calculate the absorption rate constant (ka) using the Method of Residuals (Feathering) by providing values from the residual line plot.
Understanding the Absorption Rate Constant (ka)
In pharmacokinetics, the absorption rate constant (ka) is a value that describes the rate at which a drug enters the systemic circulation from its site of administration (such as the gastrointestinal tract). It is typically represented as a first-order rate process, meaning the rate of absorption is proportional to the amount of drug remaining at the absorption site.
The Method of Residuals (Feathering)
The most common way to calculate ka from plasma concentration-time data is the Method of Residuals. This technique involves "subtracting" the extrapolated elimination phase from the actual concentration data points during the early absorption phase.
Where:
- C' represents the residual concentration values.
- t represents the corresponding time points.
- ka is the resulting absorption rate constant.
Step-by-Step Calculation Guide
- Identify the Elimination Phase: Plot your concentration vs. time data on a semi-log scale. Determine the slope of the terminal (elimination) phase.
- Extrapolate: Back-extrapolate the elimination line to the y-axis.
- Calculate Residuals: Subtract the actual observed concentration values during the absorption phase from the extrapolated elimination line values at the same time points.
- Slope of Residuals: Plot these residual values (C') against time. The negative slope of this new line is ka.
Example Calculation
Suppose you have calculated two residual points from your pharmacokinetic plot:
- At 0.5 hours, the residual concentration (C'1) is 12.0 mg/L.
- At 1.5 hours, the residual concentration (C'2) is 3.5 mg/L.
Using the formula:
ka = – [1.2527 – 2.4849] / 1.0
ka = 1.2322 hr-1
Clinical Significance
The absorption rate constant is crucial for determining the Time to Peak Concentration (Tmax) and the Peak Concentration (Cmax). A higher ka indicates faster absorption, which is often desirable for drugs requiring rapid onset of action, such as analgesics. Conversely, modified-release formulations are designed to have a low ka to provide sustained drug levels over time.